EU Clinical Trial Regulation 2022 – Impact on regulatory, labeling and QP

The EU Clinical Trial Regulation (No 536/2014) was adopted in June 2014 by the European Commission¹ and will come into force on 31 January 2022. Navigating the new regulatory changes is vital for successfully progressing complex clinical trials in the EU market and ensuring the timely supply of your Investigational Medicinal Products (IMPs).

Download this webinar to hear industry experts Harry Berlanga, Kevin Shea and Lindsey Zweig from Thermo Fisher Scientific discuss:

Related Sites

Additional Resources